-
1
-
-
39749191084
-
Heart disease and stroke statistics--2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
-
Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-146.
-
(2008)
Circulation
, vol.117
-
-
Rosamond, W.1
Flegal, K.2
Furie, K.3
-
2
-
-
33747449559
-
Peripheral arterial disease: Morbidity and mortality implications
-
Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006; 114: 688-99.
-
(2006)
Circulation
, vol.114
, pp. 688-699
-
-
Golomb, B.A.1
Dang, T.T.2
Criqui, M.H.3
-
3
-
-
33645522876
-
ACC/AHA 2005 guide-lines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive summary
-
A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation
-
Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guide-lines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary. A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006; 47: 1239-312.
-
(2006)
J Am Coll Cardiol
, vol.47
, pp. 1239-1312
-
-
Hirsch, A.T.1
Haskal, Z.J.2
Hertzer, N.R.3
-
4
-
-
0026501734
-
Mortality over a period of 10 years in patients with peripheral arterial disease
-
Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-6.
-
(1992)
N Engl J Med
, vol.326
, pp. 381-386
-
-
Criqui, M.H.1
Langer, R.D.2
Fronek, A.3
-
5
-
-
33745142203
-
Risk factors for progression of peripheral arterial disease in large and small vessels
-
Aboyans V, Criqui MH, Denenberg JO, Knoke JD, Ridker PM, Fronek A. Risk factors for progression of peripheral arterial disease in large and small vessels. Circulation 2006; 113: 2623-9.
-
(2006)
Circulation
, vol.113
, pp. 2623-2629
-
-
Aboyans, V.1
Criqui, M.H.2
Denenberg, J.O.3
Knoke, J.D.4
Ridker, P.M.5
Fronek, A.6
-
6
-
-
33751003540
-
Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events
-
Agnelli G, Cimminiello C, Meneghetti G, Urbinati S. Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events. J Thromb Haemost 2006; 4: 2599-606.
-
(2006)
J Thromb Haemost
, vol.4
, pp. 2599-2606
-
-
Agnelli, G.1
Cimminiello, C.2
Meneghetti, G.3
Urbinati, S.4
-
7
-
-
30444453441
-
International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis
-
Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180-9.
-
(2006)
JAMA
, vol.295
, pp. 180-189
-
-
Bhatt, D.L.1
Steg, P.G.2
Ohman, E.M.3
-
8
-
-
0033003013
-
Lower-extremity arteriosclerosis as a reflection of a systemic process: Implications for concomitant coronary and carotid disease
-
Dormandy J, Heeck L, Vig S. Lower-extremity arteriosclerosis as a reflection of a systemic process: implications for concomitant coronary and carotid disease. Semin Vasc Surg 1999; 12: 118-22.
-
(1999)
Semin Vasc Surg
, vol.12
, pp. 118-122
-
-
Dormandy, J.1
Heeck, L.2
Vig, S.3
-
9
-
-
34250758640
-
The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients
-
Poredos P, Jug B. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients. Angiology 2007; 58: 309-15.
-
(2007)
Angiology
, vol.58
, pp. 309-315
-
-
Poredos, P.1
Jug, B.2
-
10
-
-
42349086464
-
Risk factor profile and management of cerebrovascular patients in the REACH Registry
-
Rother J, Alberts MJ, Touze E, et al. Risk factor profile and management of cerebrovascular patients in the REACH Registry. Cerebrovasc Dis 2008; 25: 366-74.
-
(2008)
Cerebrovasc Dis
, vol.25
, pp. 366-374
-
-
Rother, J.1
Alberts, M.J.2
Touze, E.3
-
11
-
-
0034688194
-
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
-
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145-53.
-
(2000)
N Engl J Med
, vol.342
, pp. 145-153
-
-
Yusuf, S.1
Sleight, P.2
Pogue, J.3
Bosch, J.4
Davies, R.5
Dagenais, G.6
-
12
-
-
0035206979
-
PAD awareness, risk, and treatment: New resources for survival--the USA PARTNERS program
-
Hirsch AT, Hiatt WR. PAD awareness, risk, and treatment: new resources for survival--the USA PARTNERS program. Vasc Med 2001; 6: 9-12.
-
(2001)
Vasc Med
, vol.6
, pp. 9-12
-
-
Hirsch, A.T.1
Hiatt, W.R.2
-
13
-
-
0035913589
-
Peripheral arterial disease detection, awareness, and treatment in primary care
-
Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-24.
-
(2001)
JAMA
, vol.286
, pp. 1317-1324
-
-
Hirsch, A.T.1
Criqui, M.H.2
Treat-Jacobson, D.3
-
14
-
-
42649098207
-
The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program
-
Regensteiner JG, Hiatt WR, Coll JR, et al. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med 2008; 13: 15-24.
-
(2008)
Vasc Med
, vol.13
, pp. 15-24
-
-
Regensteiner, J.G.1
Hiatt, W.R.2
Coll, J.R.3
-
15
-
-
13444312019
-
Utility and barriers to performance of the ankle brachial index in primary care practice
-
Mohler ER III, Treat-Jacobson D, Reilly MP, et al. Utility and barriers to performance of the ankle brachial index in primary care practice. Vasc Med 2004; 9: 253-60.
-
(2004)
Vasc Med
, vol.9
, pp. 253-260
-
-
Mohler III, E.R.1
Treat-Jacobson, D.2
Reilly, M.P.3
-
16
-
-
77952938962
-
th Annual Scientific Session of the American College of Cardiology
-
th Annual Scientific Session of the American College of Cardiology. Orlando, FL, March 6-9, 2005.
-
(2005)
Orlando, FL, March
, pp. 6-9
-
-
Bhatt, D.L.1
Steg, P.G.2
Ohman, E.M.3
Rother, J.4
Wilson, P.W.F.5
-
17
-
-
67349127553
-
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry
-
Cacoub PP, Abola MTB, Baumgartner I, et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Athesclerosis 2009; 204: e86-92.
-
(2009)
Athesclerosis
, vol.204
-
-
Cacoub, P.P.1
Abola, M.T.B.2
Baumgartner, I.3
-
18
-
-
70549106493
-
Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US out-patients with peripheral arterial disease: Insights from the reduction of atherothrombosis for continued health (REACH) Registry
-
Meadows TA, Bhatt DL, Hirsch AT, et al. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US out-patients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) Registry. Am Heart J 2009; 158: 1038-45.
-
(2009)
Am Heart J
, vol.158
, pp. 1038-1045
-
-
Meadows, T.A.1
Bhatt, D.L.2
Hirsch, A.T.3
-
19
-
-
33947533514
-
One-year cardiovascular event rates in outpatients with atherothrombosis
-
Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007; 297: 1197-206.
-
(2007)
JAMA
, vol.297
, pp. 1197-1206
-
-
Steg, P.G.1
Bhatt, D.L.2
Wilson, P.W.3
-
20
-
-
77952949639
-
Two-year cardiovascular event rates of the cerebrovascular disease subpopulation within the REduction of Atherothrombosis for Continued Health (REACH) Registry
-
Rother J, Mas JL, Touze E, et al. Two-year cardiovascular event rates of the cerebrovascular disease subpopulation within the REduction of Atherothrombosis for Continued Health (REACH) Registry. XVII European Stroke Conference, Nice, France, May 13-16, 2008.
-
(2008)
XVII European Stroke Conference, Nice, France, May
, pp. 13-16
-
-
Rother, J.1
Mas, J.L.2
Touze, E.3
-
21
-
-
24944529933
-
Risk factors, medical therapies and perioperative events in limb salvage surgery: Observations from the PREVENT III multicenter trial
-
Conte MS, Bandyk DF, Clowes AW, Moneta GL, Namini H, Seely L. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg 2005; 45: 456-64.
-
(2005)
J Vasc Surg
, vol.45
, pp. 456-464
-
-
Conte, M.S.1
Bandyk, D.F.2
Clowes, A.W.3
Moneta, G.L.4
Namini, H.5
Seely, L.6
-
22
-
-
33746741040
-
Peripheral arterial disease vs. other localizations of vascular disease: The ATTEST study
-
Blacher J, Cacoub P, Luizy F, et al. Peripheral arterial disease vs. other localizations of vascular disease: the ATTEST study. J Vasc Surg 2006; 44: 314-8.
-
(2006)
J Vasc Surg
, vol.44
, pp. 314-318
-
-
Blacher, J.1
Cacoub, P.2
Luizy, F.3
-
23
-
-
42649133162
-
Associations between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication
-
Daskalopoulou SS, Pathmarajah M, Kakkos SK, et al. Associations between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circ J 2008; 72: 441-8.
-
(2008)
Circ J
, vol.72
, pp. 441-448
-
-
Daskalopoulou, S.S.1
Pathmarajah, M.2
Kakkos, S.K.3
-
24
-
-
33847668445
-
Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation
-
Bianchi C, Montalvo V, Ou HW, Bishop V, Abou-Zamzam AM, Jr. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation. Ann Vasc Surg 2007; 21: 163-6.
-
(2007)
Ann Vasc Surg
, vol.21
, pp. 163-166
-
-
Bianchi, C.1
Montalvo, V.2
Ou, H.W.3
Bishop, V.4
Abou-Zamzam Jr., A.M.5
-
25
-
-
0029093782
-
Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis
-
Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 1995; 274: 975-80.
-
(1995)
JAMA
, vol.274
, pp. 975-980
-
-
Gardner, A.W.1
Poehlman, E.T.2
-
26
-
-
0023188638
-
Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality
-
Jonason T, Bergstrom R. Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand 1987; 221: 253-60.
-
(1987)
Acta Med Scand
, vol.221
, pp. 253-260
-
-
Jonason, T.1
Bergstrom, R.2
-
27
-
-
43449104472
-
Dietary advice for reducing cardiovascular risk
-
Brunner EJ, Rees K, Ward K, Burke M, Thorogood M. Dietary advice for reducing cardiovascular risk. Cochrane Database Syst Rev 2007; (4): CD002128.
-
(2007)
Cochrane Database Syst Rev
, Issue.4
-
-
Brunner, E.J.1
Rees, K.2
Ward, K.3
Burke, M.4
Thorogood, M.5
-
28
-
-
32644435452
-
Effects of low-carbohydrate vs. low-fat diets on weight loss and cardiovascular risk factors: A meta-analysis of randomized controlled trials
-
Nordmann AJ, Nordmann A, Briel M, et al. Effects of low-carbohydrate vs. low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166: 285-93.
-
(2006)
Arch Intern Med
, vol.166
, pp. 285-293
-
-
Nordmann, A.J.1
Nordmann, A.2
Briel, M.3
-
29
-
-
0030813119
-
The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease
-
Hirsch AT, Treat-Jacobson D, Lando HA, Hatsukami DK. The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease. Vasc Med 1997; 2: 243-51.
-
(1997)
Vasc Med
, vol.2
, pp. 243-251
-
-
Hirsch, A.T.1
Treat-Jacobson, D.2
Lando, H.A.3
Hatsukami, D.K.4
-
30
-
-
22044432782
-
Smoking and the patency of lower extremity bypass grafts: A meta-analysis
-
Willigendael EM, Teijink JA, Bartelink ML, Peters RJ, Buller HR, Prins MH. Smoking and the patency of lower extremity bypass grafts: a meta-analysis. J Vasc Surg 2005; 42: 67-74.
-
(2005)
J Vasc Surg
, vol.42
, pp. 67-74
-
-
Willigendael, E.M.1
Teijink, J.A.2
Bartelink, M.L.3
Peters, R.J.4
Buller, H.R.5
Prins, M.H.6
-
31
-
-
33746189864
-
Relationship of smoking and smoking cessation with ankle-to-arm blood pressure index in elderly Japanese men
-
Cui R, Iso H, Yamagishi K, et al. Relationship of smoking and smoking cessation with ankle-to-arm blood pressure index in elderly Japanese men. Eur J Cardiovasc Prev Rehabil 2006; 13: 243-8.
-
(2006)
Eur J Cardiovasc Prev Rehabil
, vol.13
, pp. 243-248
-
-
Cui, R.1
Iso, H.2
Yamagishi, K.3
-
32
-
-
34249914794
-
Statins and peripheral arterial disease: Effects on claudication, disease progression, and prevention of cardiovascular events
-
Coppola G, Novo S. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events. Arch Med Res 2007; 38: 479-88.
-
(2007)
Arch Med Res
, vol.38
, pp. 479-488
-
-
Coppola, G.1
Novo, S.2
-
33
-
-
49649110690
-
The role of statin drugs in the management of the peripheral vascular patient
-
Samson RH. The role of statin drugs in the management of the peripheral vascular patient. Vasc Endovasc Surg 2008; 42: 352-66.
-
(2008)
Vasc Endovasc Surg
, vol.42
, pp. 352-366
-
-
Samson, R.H.1
-
34
-
-
67649595710
-
Vascular protection in peripheral artery disease: Systematic review and modeling study
-
Hackam DG, Sutan NM, Criqui MH. Vascular protection in peripheral artery disease: systematic review and modeling study. Heart 2009; 95: 1098-102.
-
(2009)
Heart
, vol.95
, pp. 1098-1102
-
-
Hackam, D.G.1
Sutan, N.M.2
Criqui, M.H.3
-
35
-
-
0347093525
-
The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease
-
Youssef F, Gupta P, Seifalian AM, Myint F, Mikhailidis DP, Hamilton G. The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease. Angiology 2004; 55: 53-62.
-
(2004)
Angiology
, vol.55
, pp. 53-62
-
-
Youssef, F.1
Gupta, P.2
Seifalian, A.M.3
Myint, F.4
Mikhailidis, D.P.5
Hamilton, G.6
-
36
-
-
0037031061
-
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
-
Heart Protection Study Collaborative Group
-
Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
37
-
-
33747052530
-
Can statins reduce perioperative morbidity and mortality in patients under-going non-cardiac vascular surgery?
-
Paraskevas KI, Liapis CD, Hamilton G, Mikhailidis DP. Can statins reduce perioperative morbidity and mortality in patients under-going non-cardiac vascular surgery? Eur J Vasc Endovasc Surg 2006; 32: 286-93.
-
(2006)
Eur J Vasc Endovasc Surg
, vol.32
, pp. 286-293
-
-
Paraskevas, K.I.1
Liapis, C.D.2
Hamilton, G.3
Mikhailidis, D.P.4
-
38
-
-
25644456061
-
The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery
-
Ward RP, Leeper NJ, Kirkpatrick JN, Lang RM, Sorrentino MJ, Williams KA. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol 2005; 104: 264-8.
-
(2005)
Int J Cardiol
, vol.104
, pp. 264-268
-
-
Ward, R.P.1
Leeper, N.J.2
Kirkpatrick, J.N.3
Lang, R.M.4
Sorrentino, M.J.5
Williams, K.A.6
-
39
-
-
0025992650
-
Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials
-
Radack K, Deck C. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. Arch Intern Med 1991; 151: 1769-76.
-
(1991)
Arch Intern Med
, vol.151
, pp. 1769-1776
-
-
Radack, K.1
Deck, C.2
-
40
-
-
0035371384
-
Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease
-
Aronow WS, Ahn C. Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease. Am J Cardiol 2001; 87: 1284-6.
-
(2001)
Am J Cardiol
, vol.87
, pp. 1284-1286
-
-
Aronow, W.S.1
Ahn, C.2
-
41
-
-
1542299133
-
The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease
-
Jagroop IA, Matsagas MI, Geroulakos G, Mikhailidis DP. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease. Platelets 2004; 15: 117-25.
-
(2004)
Platelets
, vol.15
, pp. 117-125
-
-
Jagroop, I.A.1
Matsagas, M.I.2
Geroulakos, G.3
Mikhailidis, D.P.4
-
42
-
-
0037065502
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
-
Antithrombotic Trialists' Collaboration
-
Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
43
-
-
0030590746
-
A randomised, blinded, trial of clopidogrel vs. aspirin in patients at risk of ischaemic events (CAPRIE)
-
CAPRIE Steering Committee
-
CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel vs. aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
-
(1996)
Lancet
, vol.348
, pp. 1329-1339
-
-
-
44
-
-
65549105821
-
Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: A meta-analysis of randomized trial
-
Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trial. JAMA 2009; 301: 1909-19.
-
(2009)
JAMA
, vol.301
, pp. 1909-1919
-
-
Berger, J.S.1
Krantz, M.J.2
Kittelson, J.M.3
Hiatt, W.R.4
-
45
-
-
0036592798
-
Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100
-
Roller RE, Dorr A, Ulrich S, Pilger E. Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100. Blood Coagul Fibrinolysis 2002; 13: 277-81.
-
(2002)
Blood Coagul Fibrinolysis
, vol.13
, pp. 277-281
-
-
Roller, R.E.1
Dorr, A.2
Ulrich, S.3
Pilger, E.4
-
46
-
-
33745325634
-
Overcoming aspirin resistance: Increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease
-
Wong S, Morel-Kopp MC, Chen Q, Appleberg M, Ward CM, Lewis DR. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease. Thromb Haemost 2006; 95: 1042-3.
-
(2006)
Thromb Haemost
, vol.95
, pp. 1042-1043
-
-
Wong, S.1
Morel-Kopp, M.C.2
Chen, Q.3
Appleberg, M.4
Ward, C.M.5
Lewis, D.R.6
-
47
-
-
69249211258
-
Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up
-
Linnemann B, Prochow S, Mani H, Schwonberg J, Lindhoff-Last E. Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up. Ann Hematol 2009; 88: 979-88.
-
(2009)
Ann Hematol
, vol.88
, pp. 979-988
-
-
Linnemann, B.1
Prochow, S.2
Mani, H.3
Schwonberg, J.4
Lindhoff-Last, E.5
-
48
-
-
9844224482
-
Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty
-
Mueller MR, Salat A, Stangl P, et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 1997; 78: 1003-7.
-
(1997)
Thromb Haemost
, vol.78
, pp. 1003-1007
-
-
Mueller, M.R.1
Salat, A.2
Stangl, P.3
-
49
-
-
29244439006
-
Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: A randomized crossover trial
-
Eikelboom JW, Hankey GJ, Thom J, et al. Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial. J Thromb Haemost 2005; 3: 2649-55.
-
(2005)
J Thromb Haemost
, vol.3
, pp. 2649-2655
-
-
Eikelboom, J.W.1
Hankey, G.J.2
Thom, J.3
-
50
-
-
33645861080
-
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
-
Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354: 1706-17.
-
(2006)
N Engl J Med
, vol.354
, pp. 1706-1717
-
-
Bhatt, D.L.1
Fox, K.A.2
Hacke, W.3
-
51
-
-
58449114663
-
Patients with peripheral arterial disease in the CHARISMA trial
-
Cacoub PP, Bhatt DL, Steg PG, Topol EJ, Creager MA. Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J 2009; 30: 192-201.
-
(2009)
Eur Heart J
, vol.30
, pp. 192-201
-
-
Cacoub, P.P.1
Bhatt, D.L.2
Steg, P.G.3
Topol, E.J.4
Creager, M.A.5
-
53
-
-
77952918209
-
Belch J on behalf of the CASPAR investigators. Effect of adding clopidogrel to aspirin on the success of below knee arterial bypass grafts
-
Vascular Annual Meeting, Baltimore, MD, June 6-10
-
Dormandy J, Belch J on behalf of the CASPAR investigators. Effect of adding clopidogrel to aspirin on the success of below knee arterial bypass grafts. A randomized placebo controlled study. Vascular Annual Meeting, Baltimore, MD, June 6-10, 2007.
-
(2007)
A Randomized Placebo Controlled Study
-
-
Dormandy, J.1
-
55
-
-
25644457532
-
Cilostazol reduced target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery
-
Iida O, Nanto S, Uematsu M, et al. Cilostazol reduced target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery. Circ J 2005; 69: 1256-9.
-
(2005)
Circ J
, vol.69
, pp. 1256-1259
-
-
Iida, O.1
Nanto, S.2
Uematsu, M.3
-
56
-
-
45549101498
-
Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions
-
Iida O, Nanto S, Uematsu M, Morozumi T, Kitakaze M, Nagata S. Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions. J Vasc Surg 2008; 48: 144-9.
-
(2008)
J Vasc Surg
, vol.48
, pp. 144-149
-
-
Iida, O.1
Nanto, S.2
Uematsu, M.3
Morozumi, T.4
Kitakaze, M.5
Nagata, S.6
-
57
-
-
57949090058
-
Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication
-
Soga R, Yokoi H, Kawasaki T, et al. Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication. J Am Coll Cardiol 2009; 53: 48-53.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 48-53
-
-
Soga, R.1
Yokoi, H.2
Kawasaki, T.3
-
58
-
-
0038165393
-
A strategy to reduce cardiovascular disease by more than 80%
-
Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003; 326: 1419.
-
(2003)
BMJ
, vol.326
, pp. 1419
-
-
Wald, N.J.1
Law, M.R.2
-
59
-
-
34250731233
-
Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events)
-
Mukherjee D, Eagle KA, Kline-Rogers E, et al. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol 2007; 100: 1-6.
-
(2007)
Am J Cardiol
, vol.100
, pp. 1-6
-
-
Mukherjee, D.1
Eagle, K.A.2
Kline-Rogers, E.3
-
60
-
-
0035942767
-
Medical treatment of peripheral arterial disease and claudication
-
Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 1608-21.
-
(2001)
N Engl J Med
, vol.344
, pp. 1608-1621
-
-
Hiatt, W.R.1
-
61
-
-
31744451141
-
Automated oscillometric determination of the ankle-brachial index provides accuracy necessary for office practice
-
Beckman JA, Higgins CO, Gerhard-Herman M. Automated oscillometric determination of the ankle-brachial index provides accuracy necessary for office practice. Hypertension 2006; 47: 35-8.
-
(2006)
Hypertension
, vol.47
, pp. 35-38
-
-
Beckman, J.A.1
Higgins, C.O.2
Gerhard-Herman, M.3
-
62
-
-
0033552883
-
Atherosclerosis--an inflammatory disease
-
Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340: 115-26.
-
(1999)
N Engl J Med
, vol.340
, pp. 115-126
-
-
Ross, R.1
-
63
-
-
34248173609
-
Antiplatelet therapy for atherothrombotic disease: An update for the primary care physician
-
Kikano GE, Brown MT. Antiplatelet therapy for atherothrombotic disease: an update for the primary care physician. Mayo Clin Proc 2007; 82: 583-93.
-
(2007)
Mayo Clin Proc
, vol.82
, pp. 583-593
-
-
Kikano, G.E.1
Brown, M.T.2
|